Verified Nov 2026
Other
·

London, England
·
Since 2021
invoX Pharma is a biopharmaceutical company founded in 2021 and headquartered in London, England, with 50–100 employees. A wholly-owned subsidiary of Sino Biopharmaceutical Limited, it focuses on oncology and respiratory disease treatment through research, clinical development, and business development across the UK, EU, and US. The company develops bispecific antibodies and respiratory delivery systems, including its Softhaler® soft mist inhaler platform.
invoX Pharma at a glance
Employees
50-100
Founded
2021
Headquarters
London, England
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Operating
5 years in operation (founded 2021).
Holds ISO 13485 certification(s) per public sources.
Overview
invoX Pharma is a biopharmaceutical company founded in 2021 and headquartered in London, England, with 50–100 employees. A wholly-owned subsidiary of Sino Biopharmaceutical Limited, it focuses on oncology and respiratory disease treatment through research, clinical development, and business development across the UK, EU, and US. The company develops bispecific antibodies and respiratory delivery systems, including its Softhaler® soft mist inhaler platform.
At a glance
Attribute | Detail |
|---|---|
Founded | 2021 |
Headquarters | London, England |
Employees | 50-100 |
Certifications | ISO 13485 |
What invoX Pharma makes
invoX Pharma holds ISO 13485 certification and develops bispecific antibodies and pharmaceutical inhalation products for pulmonary drug delivery.
Products and capabilities described on the company's own site include Assembly, Sub-Assembly (source: invoxpharma.com).
Certifications
invoX Pharma is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — invoxpharma.com
Latest developments
2026-11-06 — Invox Pharma stops Phase 1 FS120 study in advanced cancer | trialticker (trialticker.com)
2026-07-02 — A fantastic week for invoX at the Convention, and a thank you to everyone who took the time to connect with us. | invoX (linkedin.com)
2026-03-05 — We're delighted to announce that invoX have selected CARA for R&D Content & Process Management! We look forward to working together. | Generis (linkedin.com)
2026-01-16 — We are hiring at invoX! | Kobe Kerkhofs (linkedin.com)
2025-10-31 — invoX is excited to be attending BIO-Europe 2025. It’s a fantastic opportunity to connect with global leaders in biotech and pharma, explore new partnerships, and discuss the latest innovations. | invoX (linkedin.com)
2025-04-04 — Two years after completing its $161 million cash exit to Sino Biopharmaceutical's invoX Pharma (following CFIUS review), F-star Therapeutics is returning to an independent biotech. Its management team bought out the UK … | Kyle LaHucik (linkedin.com)
Company details
The company operates as a subsidiary of Sino Biopharmaceutical Limited and maintains R&D operations across multiple geographies to serve healthcare providers and patients globally. invoX Pharma was founded in 2021, has an estimated 50-100 employees, and is headquartered in London, England. On the LightSource stability read it is rated "Operating": 5 years in operation (founded 2021). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does invoX Pharma do?
invoX Pharma is a biopharmaceutical company founded in 2021 and headquartered in London, England, with 50–100 employees. A wholly-owned subsidiary of Sino Biopharmaceutical Limited, it focuses on oncology and respiratory disease treatment through research, clinical development, and business development across the UK, EU, and US. The company develops bispecific antibodies and respiratory delivery systems, including its Softhaler® soft mist inhaler platform.
Where is invoX Pharma headquartered?
invoX Pharma is headquartered in London, England (165 Wood Lane, London, England, W12 7ED).
When was invoX Pharma founded?
invoX Pharma was founded in 2021.
How big is invoX Pharma?
invoX Pharma has an estimated 50-100 employees.
What certifications does invoX Pharma hold?
invoX Pharma lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
